Home  |  Publications  |  Conferences   |  Join  |  Contact
                           
 
ISSN: 2157-7560

Journal of Vaccines & Vaccination

Open Access
 
 
OMICS International organises 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes
700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
 
 
 
 
 
 
 

Editor-in-Chief

Editor in Chief Editor-in-Chief
Nikolai Petrovsky
Professor
Director of Endocrinology Medicine
Flinders University
Australia

Submit Manuscript

Impact Factor 1.80*

Submit manuscript at http://www.editorialmanager.com/pharma/ or send as an e-mail attachment to the Editorial Office at editor.jvv@omicsonline.org
 

About the Journal

Over View

Journal of Vaccines & Vaccination is a peer reviewed Journal publishing then articles on different classification keywords like Human Vaccine Trials, Veterinary Vaccines, Cancer Vaccines, Vaccine Adjuvants, Vaccine regulatory issues, Preclinical vaccine studies, Childhood vaccines, HIV vaccines, Malaria vaccines, TB vaccines, etc.,

Emerging practices and the experiences in this field needs a critical and thorough discussion to spread the knowledge so that the researchers adopt them to pass on the benefits to the needy. The Journal of Vaccines & Vaccination accepts articles in the form of research articles, review articles, short communications, letter to editors, commentaries, case reports, etc. This Vaccines journal is a open access scholarly journal dedicated towards distribution of valuable information for the societal benefit.

Articles published in this journal are subjected to rigorous review and revision process before being accepted for publication, to maintain quality and the standards set for academic journals. This Journal ensures the barrier-free distribution of its content through online free access and thus helps in improving the citations for authors and attaining high impact factor.

Authors are requested to submit manuscripts at www.editorialmanager.com/pharma/ or send as an e-mail attachment to the Editorial Office at editor.jvv@omicsonline.org

OMICS International organizes 1000+ conferences every year across USA, Europe & Asia with support from more than 1000 scientific societies and publishes 700+ open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Vaccine

Vaccine can be defined as a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically consists of a disease-causative microorganism which is often prepared from killed or inactivated forms of the microbe, its toxins or one of its surface proteins. This agent stimulates the body's immune system to recognize it as threat, destroy it, and maintain a record of it, and any such successive similar infection can be more easily recognized by the immune system and destroyed.

Vaccination

Vaccination can be defined as the process of administration of an antigenic material (vaccine) into a living mechanism. The clinical effect desired is to cause stimulation of an individual's immune system in order to develop an adaptive immunity against the pathogen constituting the vaccine. Vaccination is the most effective method of prevention for infectious diseases.

Cancer Vaccines

Cancer vaccine can be defined as a vaccine employed in treatment of cancer. Cancer vaccines can either therapeutic or preventive. Vaccines that treat existing cancer are known as therapeutic cancer vaccines; whereas vaccines given to healthy individuals to protect against cancer-causing viruses like the human papillomavirus (HPV) and hepatitis B virus (HBV) can be termed as cancer preventive vaccines.

Vaccine Adjuvants

Vaccine Adjuvants – It can be defined as a component which potentiates the immune system and accelerates the immune responses to an antigen. It can also be termed as an immunologic adjuvant. These components act to induce, prolong, and enhance antigen-specific immune responses when used in combination with specific vaccine antigens.

Vaccine Regulatory Issues

Vaccine regulatory issues - The issues/regulatory principles responsible for regulation of vaccines, their production, distribution and control can be termed as vaccine regulatory issues. Typical issues and conflicts that arise in the research and experimentation field involving vaccines can also be grouped and dealt under vaccine regulatory issues.

Preclinical Vaccine Studies

Preclinical vaccine studies - These studies are performed prior to clinical trials and can be termed as “Preclinical vaccines studies”. These studies are performed to evaluate the safety, immunogenicity and therapeutic desirability of the vaccines in different animal models. These are nonclinical studies performed by vaccine manufacturers prior to clinical testing.

Childhood Vaccines

Childhood vaccines – Vaccines that ought to be administered to humans during childhood stage of life can be termed as childhood vaccines. These vaccines are primarily responsible for the induction of immune system and development of immunogenic response within the child.

HIV Vaccines Research & Development

HIV vaccines Research & Development – The field of research includes research work that is carried against HIV, its infection, symptoms, treatment and prevention. Vaccines developed against HIV can be studied under this branch of science. The field of research thus enables development of vaccines against HIV. A few such vaccines include “RV380 (AD26 prime/MVA boost)”, “RV262 (DNA prime/MVA boost)” and “Novel Herion-HIV Vaccine”.

Malaria Vaccines

Malaria vaccines - Vaccines employed for the treatment of malaria can be grouped as malarial vaccines. The field of research includes vaccines developed against malaria, current vaccine research being carried and clinical advancements in the fields of malarial treatment. The most recent advancement in the field of malarial treatment is the artemisinin-combination drug therapy.

Tuberculosis Vaccines

Tuberculosis vaccines (TB vaccines) – Vaccines employed for the prevention of Tuberculosis can be termed as tuberculosis vaccines. These cause induction of immune response against the microbe responsible for the infection and causes development of immunogenic response within the infected system. The only approved successful vaccine against malaria is Bacilli Calmette-Guérin (BCG) vaccine.

Veterinary Vaccines

Veterinary Vaccines - Vaccines employed for the prevention of various diseases that affect animals can be grouped under veterinary vaccines. The field of research includes vaccines developed against many veterinary diseases, the methods for their prevention and their treatment.

Vaccines Epidemiology

Vaccines epidemiology – The field of science that deals with the evaluation techniques and methods involved in the evaluation of vaccines is vaccine epidemiology. The overall aim of the field of research is to provide an understanding about various methods and techniques involved in evaluation of vaccines and immunization.

Vaccines Dermatology

Vaccines dermatology – Vaccines that are employed for the prevention of dermatological infections and diseases can be grouped as dermatological vaccines. The field of research that relates the fields of vaccination and dermatological infections can be named as vaccines dermatology. Acne, one of the most common skin diseases can be treated in this manner, involving dermatological vaccinations.

Vaccines Immunology

Vaccines Immunology - The field of research that deals with vaccines and their immunisational effects is vaccines immunology. The field deals with immunological vaccines such as immune-globulins, their synthesis, development and therapeutic desirability and compatibility.

Ebola Vaccines

Ebola Vaccines – Vaccines employed for prevention of Ebola disease are Ebola vaccines. The vaccines for prevention of Ebola infections are developed, but no vaccine is approved for treatment in humans. The vaccines developed resemble recombinant vector vaccines and include Replication-deficient adenovirus vectors, Replication-competent vesicular stomatitis (VSV) and Human parainfluenza (HPIV-3) vectors as examples.

Vaccine Research & Development

Vaccine Research & Development – The field deals collectively with various kinds of vaccines, their synthesis, therapeutic effects and clinical developments. The field entirely covers all the advancements, developments of vaccines in every field of vaccination. Vaccines treating malaria, cancer and many other diseases can be collectively studied under this field.

Component Vaccines

Component Vaccines – Vaccines that are employed in combination therapy for certain diseases can be termed as component vaccines. These are clinical vaccines discovered and employed for combination therapies.

Recombinant Vector Vaccines

Recombinant Vector Vaccines – Vaccines that are made available for administration in combination with recombinant vectors can be termed as recombinant vector vaccines. These vaccines involve the introduction of vaccine component into a recombinant vector, to prevent the degradation of vaccine component if susceptible for such degradation. Recombinant Vaccinia Virus Vaccine is an example for recombinant vaccine.

Immunotherapeutics

Immunotherapeutics – The field of research that deals with treatment of certain diseases involving immune therapy can be termed as Immunotherapeutics. The method involves treatment of disease by inducing, enhancing, or suppressing an immune response. Immunotherapies that are designed to elicit or amplify an immune response can be classified as activation immunotherapies, while immunotherapies that reduce or suppress immune responses are termed as suppression immunotherapies.

Autism Vaccines

Autism Vaccines – Vaccines employed for prevention of autism development can be grouped and dealt under autism vaccines. Autism is a neuro developmental disorder that can be developed in children due to regular and repetitive vaccinations for various other diseases. Hence autism vaccine research is a typical field of research and study.

Human Papilloma Virus Vaccine

Human Papilloma Virus Vaccine (HPV Vaccines) –The vaccine is employed for the treatment of Human Papilloma Virus infection. Human Papillomavirus (HPV) is a common virus that is spread through sexual contact. Clinical diagnosis of the disease is difficult is difficult as the disease does not present any symptoms. Hence vaccination is of much importance.

Polio Vaccines

Polio Vaccines – The vaccine employed for prevention of infection by Poliomyelitis virus is Polio vaccine. The vaccine consists of live and attenuated strains of all the three strains of poliomyelitis viruses. The first polio vaccine was developed by Jonas Salk by the use of HeLa cells, which consists of an inactivated (dead) poliomyelitis virus.

MMR Vaccines

MMR Vaccines - The MMR vaccine is an immunization vaccine against Measles, Mumps, and Rubella (German measles). The vaccine contains a mixture of live attenuated viruses of three diseases, administered together parentally. MMR vaccine was first developed by Maurice Hilleman. MMR is a two-shot series of vaccines usually given during childhood. The first dose of vaccine is to be given when between 12-15 months of age, and the second dose at an age of 4-6 years.

Tdap Vaccines

Tdap Vaccines - Tdap vaccine is a combination vaccine that prevents infection against three bacterial diseases: Tetanus, Diphtheria, and Pertussis (whooping cough). Tdap vaccine in all forms is composed of tetanus and diphtheria toxoids with acellular pertussis.

Chicken pox Vaccines

Chicken pox Vaccines - The vaccine employed in treatment of chickenpox. It can also be termed as Varicella vaccine, because chickenpox is caused by the varicella-zoster virus. The vaccine is prepared from live but weakened, or attenuated strains of the virus. The varicella vaccine is initially given parentally between age of 12 and 15 months and a booster dose for further prevention is given at an age of 4 to 6 years.

Journal of Vaccines & Vaccination is organizing 5th American Global summit and Expo on Vaccines & Vaccination during October 5-7, 2015 at San Francisco, USA with the theme "Prospects and Development of Prophylactic & Therapeutic Vaccines".

 

*Unofficial 2014 Impact Factor was established by dividing the number of articles published in 2012 and 2013 with the number of times they are cited in 2014 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2012 and 2013, and ‘Y’ is the number of times these articles were cited in indexed journals during 2014 than, impact factor = Y/X

 

Recently published articles

 
Comparative Study on Bacterial Outer Membrane Protein (BOMP) and Bacterial Outer Membrane Gene (BOMPG) Vaccination to Goldfish Carassius Auratus against Aeromonas Hydrophila

Sekar Divya, Vijayaragavan Thangaviji, Subramanian Velmurugan, Mariavincent Michaelbabu and Thavasimuthu Citarasu

 
Immunization of Female Mice with a Plasmid DNA Vaccine Coding Eight Repeats of Gonadotrophin Releasing Hormone(Gnrh-I) and Eight T-Helper Epitopes Suppress Fertility In Vivo

Mohammad Abu Hadi Khan, Umme Kulsum Rima, Tadashi Kimura, Ayman M Gebril, Mohammad Taimur Islam, Abu Saleh Mahfuzul Bari, Valerie Anne Ferro and Mohammad Abu Hadi Khan

 
DNA Vaccines: How Much Have We Accomplished In The Last 25 Years?

Daniela Santoro Rosa, Juliana de Souza Apostólico and Silvia Beatriz Boscardin

 
 
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2015-16
 
Meet Inspiring Speakers and Experts at our 1000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@openaccessjournals.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@openaccessjournals.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@openaccessjournals.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@openaccessjournals.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

agrifoodaquavet@openaccessjournals.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@openaccessjournals.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@openaccessjournals.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@openaccessjournals.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@openaccessjournals.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@openaccessjournals.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@openaccessjournals.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@openaccessjournals.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@openaccessjournals.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@openaccessjournals.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@openaccessjournals.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@openaccessjournals.com

1-702-714-7001 Extn: 9042

 
© 2008-2015 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version